Results 111 to 120 of about 2,608,939 (298)

Discovery and Optimization of AMT‐676, a CDH17‐Targeting ADC for the Treatment of Advanced Gastrointestinal Cancers

open access: yesAdvanced Science, EarlyView.
AMT‐676 is a novel antibody‐drug conjugate targeting CDH17, an adhesion molecule uniquely exposed on gastrointestinal tumor surfaces. Engineered with an optimized exatecan payload, it demonstrates profound tumor regression and a robust bystander effect across diverse preclinical models.
Ying‐nan Wang   +21 more
wiley   +1 more source

Applying toponome imaging system for studying colon cancer [PDF]

open access: yes
Introduction In a proof of principle study, we have applied an automated fluorescence toponome imaging system (TIS) in order to examine, whether TIS can find protein network structures distinguishing cancerous from normal colon tissue from same ...
Bhattacharya, Sayantan
core  

FOXP1 Knockdown Reprograms Th9 CAR‐T Cells to Overcome Antigen Escape

open access: yesAdvanced Science, EarlyView.
FOXP1 knockdown enhances Th9 CAR‐T cell function by promoting IL‐9 production, effector activation, and reduced exhaustion. Reprogrammed Th9 CAR‐T cells strengthen direct tumor killing and activate endogenous antitumor immunity through dendritic cells and CD8+ T cells, thereby suppressing both antigen‐positive and antigen‐loss tumor growth and ...
Yihan Zhu   +14 more
wiley   +1 more source

A hybrid architecture with separable convolutions and attention for lung and colon cancer detection

open access: yesArray
Early and accurate detection of lung and colon cancer is critical for improving patient survival rates. However, conventional classification techniques often struggle with the complexity of medical imaging data.
Md. Darun Nayeem   +7 more
doaj   +1 more source

Dual‐Target Nectin‐4/FAP Heterobivalent Probe 68Ga/177Lu‐FZ‐NF‐1 for Triple‐Negative Breast Cancer: Preclinical Theranostic Evaluation and First‐in‐Human Translation

open access: yesAdvanced Science, EarlyView.
A novel hetero‐bivalent agent, 68Ga/177Lu‐FZ‐NF‐1, concurrently targets Nectin‐4 and FAP in triple‐negative breast cancer. It yields significant preclinical tumor regression and clinically identifies additional metastatic lesions missed by 18F‐FDG PET, demonstrating promising theranostic potential for personalized management.
Ye Li   +13 more
wiley   +1 more source

Exploration of exact significance of lymph node ratio and construction of a novel stage in colon cancer with no distant metastasis

open access: yesCancer Management and Research, 2019
Yang Lv,1,* Qing-Yang Feng,1,* Song-Bin Lin,2,* Yi-Hao Mao,1,* Yu-Qiu Xu,1 Peng Zheng,1 Liang-Liang Yang,1 Guo-Dong He,1 Jian-Min Xu11Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, People’s Republic of China ...
Lv Y   +8 more
doaj  

Exploring the mystery of colon cancer from the perspective of molecular subtypes and treatment

open access: yesScientific Reports
The molecular categorization of colon cancer patients remains elusive. Gene set enrichment analysis (GSEA), which investigates the dysregulated genes among tumor and normal samples, has revealed the pivotal role of epithelial-to-mesenchymal transition ...
Wenhong Lu   +3 more
doaj   +1 more source

STUDIES ON THE CLASSIFICATION OF THE COLON-TYPHOID GROUP [PDF]

open access: yesAmerican Journal of Public Health, 1916
J B, Thomas, E A, Sandman
openaire   +2 more sources

Ribonucleotides Amplify Mitochondrial DNA‐Driven cGAS–STING Activation via FdUMP‐ribonucleotide Hybrid Particles to Potentiate Chemoimmunotherapy

open access: yesAdvanced Science, EarlyView.
This work develops a metabolic sharing strategy that employs cytidine monophosphate (CMP) to competitively reprogram floxuridine (FUDR) pyrimidine metabolism in colorectal tumor cells. Elevated intracellular FdUMP induces nucleotide imbalance, drives mitochondrial DNA release and cGAS‐STING innate immune cascade activation, and potentiates robust ...
Chao Wang   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy